Literature DB >> 7675224

Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis.

H Tumani1, G Nölker, H Reiber.   

Abstract

We describe the specificity and sensitivity of measuring a combination of basic CSF variables and Borrelia burgdorferi (Bb)-specific IgG and IgM antibody index (AI) values for the diagnosis of early neuroborreliosis. Basic CSF variables included total cell count, quantitation of activated B cells (IgG, IgA, and IgM classes), CSF/serum quotient diagrams for IgG, IgA, and IgM (to quantitate brain-derived immunoglobulin fractions in CSF), and CSF/serum albumin ratio as a measure of blood-CSF barrier function. The Bb-specific component of immunoglobulins in CSF and serum was quantitated by ELISA. Results are based on data from CSF and serum of 24 patients with definite neuroborreliosis, 45 patients with other neurologic diseases, and 28 control individuals. Combined evidence of an elevated CSF cell count, IgM-class dominance in both the cellular and intrathecal humoral immune response, and blood-CSF barrier dysfunction yielded 70% diagnostic sensitivity and 98% diagnostic specificity for detection of neuroborreliosis. Intrathecal production of Bb-specific IgM, evaluated as Bb-specific IgM antibody index (Bb-IgM-AI; pathologic value > 1.4) showed 79% diagnostic sensitivity and 96% diagnostic specificity. Correspondingly, elevated Bb-specific IgG antibody index (Bb-IgG-AI; pathologic value > 1.4) displayed 63% diagnostic sensitivity and 89% diagnostic specificity. Combined analysis of Bb-specific AI values and basic CSF variables gave the highest sensitivity (80%) and specificity (98%). Analysis of CSF variables over a disease course showed that acute versus past disease could be discriminated by a combination of basic CSF variables and Bb-specific AI.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675224     DOI: 10.1212/wnl.45.9.1663

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  The neurological disorder associated with thyroid autoimmunity.

Authors:  Franco Ferracci; Antonio Carnevale
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

2.  Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance.

Authors:  J Bednárova
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

3.  Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis.

Authors:  Gerold Stanek; Lara Lusa; Katarina Ogrinc; Mateusz Markowicz; Franc Strle
Journal:  Med Microbiol Immunol       Date:  2013-12-23       Impact factor: 3.402

4.  [Cytokine CXCL13--a possible early CSF marker for neuroborreliosis].

Authors:  T A Rupprecht; U Koedel; B Angele; V Fingerle; H-W Pfister
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

5.  Clinical Reasoning: A 20-year-old man with headache and double vision.

Authors:  Khaled Moussawi; Anoopum Gupta; Haatem Reda
Journal:  Neurology       Date:  2016-10-11       Impact factor: 9.910

Review 6.  [Neuroborreliosis - Diagnostics, treatment and course].

Authors:  R Dersch; S Rauer
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 7.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

8.  Cerebrospinal fluid proteome of patients with acute Lyme disease.

Authors:  Thomas E Angel; Jon M Jacobs; Robert P Smith; Mark S Pasternack; Susan Elias; Marina A Gritsenko; Anil Shukla; Edward C Gilmore; Carol McCarthy; David G Camp; Richard D Smith; H Shaw Warren
Journal:  J Proteome Res       Date:  2012-08-31       Impact factor: 4.466

9.  CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Authors:  Unn Ljøstad; Ase Mygland
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

10.  Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

Authors:  Henrik Zetterberg; Niklas Mattsson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.